NCT00532077View on ClinicalTrials.gov

A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Osteoporosis
Interventions
DRUG

rhPTH(1-34)

DRUG

SB-751689 100 mg

DRUG

SB-751689 400 mg

Trial Locations (5)

32117

GSK Investigational Site, Daytona Beach

32127

GSK Investigational Site, Port Orange

78752

GSK Investigational Site, Austin

92123

GSK Investigational Site, San Diego

96813

GSK Investigational Site, Honolulu

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY